Table 1. Primers targeting human integrins, E-cadherin and vimentin.
| Target | Forward primer (5'-3') | Reverse primer (5'-3') |
|---|---|---|
| Alpha1 | GGTTCCTACTTTGGCAGTATT | AACCTTGTCTGATTGAGAGCA |
| Alpha2 | GGAACGGGACTTTCGCAT | GGTACTTCGGCTTTCTCATCA |
| Alpha3 | AAGGGACCTTCAGGTGCA | TGTAGCCGGTGATTTACCAT |
| Alpha6 | TTGAATATACTGCTAACCCCG | TCGAAACTGAACTCTTGAGGATAG |
| Alpha7 | CTGTTTCAGCTACATTGCAGTC | GCCTGGTGCTTGGGTTCT |
| AlphaV | AATCTTCCAATTGAGGATATCAC | AAAACAGCCAGTAGCAACAAT |
| Beta1 | GAAGGGTTGCCCTCCAGA | GCTTGAGCTTCTCTGCTGTT |
| Beta4 | AGACGAGATGTTCAGGGACC | GGTCTCCTCTGTGATTTGGAA |
| Beta5 | GGAGCCAGAGTGTGGAAACA | GAAACTTTGCAAACTCCCTC |
| Beta6 | TCAGCGTGACTGTGAATATCC | GTGACATTTGGAGCTGTTCAC |
| Beta8 | AATTTGGTAGTGGAAGCCTATC | GTCACGTTTCTGCATCCTTC |
| Actin | GCTGTGCTACGTCGCCCTG | GGAGGAGCTGGAAGCAGCC |
| CycloA | CTCGAATAAGTTTGACTTGTGTTT | CTAGGCATGGGAGGGAACA |
| E-Cadherin | ACAGCCCCGCCTTATGATT | TCGGAACCGCTTCCTTCA |
| Vimentin | AAGAGAACTTTGCCGTTGAA | GTGATGCTGAGAAGTTTCGT |